Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

Articles published in
J Immunol
    August 2022
  1. DAI M, Sun H, Zhao L, Wu Q, et al
    Duck CD8(+) T Cell Response to H5N1 Highly Pathogenic Avian Influenza Virus Infection In Vivo and In Vitro.
    J Immunol. 2022 Aug 8. pii: jimmunol.2101147. doi: 10.4049/jimmunol.2101147.
    >> Share

  2. CIPOLLA EM, Yue M, Nickolich KL, Huckestein BR, et al
    Heterotypic Influenza Infections Mitigate Susceptibility to Secondary Bacterial Infection.
    J Immunol. 2022 Aug 1. pii: jimmunol.2200261. doi: 10.4049/jimmunol.2200261.
    >> Share

    July 2022
  3. PEREZ MM, Pimentel VE, Fuzo CA, da Silva-Neto PV, et al
    Acetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity.
    J Immunol. 2022;209:250-261.
    >> Share

  4. PALANI S, Bansal S, Verma AK, Bauer C, et al
    Type I IFN Signaling Is Essential for Preventing IFN-gamma Hyperproduction and Subsequent Deterioration of Antibacterial Immunity during Postinfluenza Pneumococcal Infection.
    J Immunol. 2022;209:128-135.
    >> Share

    June 2022
  5. CUSIMANO GM, Gary EN, Bell MR, Warner BM, et al
    Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1.
    J Immunol. 2022 Jun 24. pii: jimmunol.2200056. doi: 10.4049/jimmunol.2200056.
    >> Share

  6. SEBINA I, Rashid RB, Sikder MAA, Rahman MM, et al
    IFN-lambda Diminishes the Severity of Viral Bronchiolitis in Neonatal Mice by Limiting NADPH Oxidase-Induced PAD4-Independent NETosis.
    J Immunol. 2022;208:2806-2816.
    >> Share

  7. CHEN Y, Ye Z, Zhang Y, Xie W, et al
    A Deep Learning Model for Accurate Diagnosis of Infection Using Antibody Repertoires.
    J Immunol. 2022;208:2675-2685.
    >> Share

  8. NAGASHIMA K, Dzimianski JV, Han J, Abbadi N, et al
    The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines.
    J Immunol. 2022 Jun 13. pii: jimmunol.2101171. doi: 10.4049/jimmunol.2101171.
    >> Share

  9. LOUIE AY, Tingling J, Dray E, Hussain J, et al
    Dietary Cholesterol Causes Inflammatory Imbalance and Exacerbates Morbidity in Mice Infected with Influenza A Virus.
    J Immunol. 2022;208:2523-2539.
    >> Share

  10. JERGOVIC M, Coplen CP, Uhrlaub JL, Beitel SC, et al
    Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved.
    J Immunol. 2022;208:2461-2465.
    >> Share

    May 2022
  11. TAN HX, Wragg KM, Kelly HG, Esterbauer R, et al
    Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil.
    J Immunol. 2022;208:2267-2271.
    >> Share

  12. LI H, Zhao M, Zhang H, Quan C, et al
    Pneumonia Severity and Phase Linked to Virus-Specific T Cell Responses with Distinct Immune Checkpoints during pH1N1 Infection.
    J Immunol. 2022;208:2154-2162.
    >> Share

    April 2022
  13. HOUSER CL, Lawrence BP
    The Aryl Hydrocarbon Receptor Modulates T Follicular Helper Cell Responses to Influenza Virus Infection in Mice.
    J Immunol. 2022 Apr 20. pii: jimmunol.2100936. doi: 10.4049/jimmunol.2100936.
    >> Share

  14. GOMEZ-LOPEZ N, Romero R, Tao L, Gershater M, et al
    Distinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women.
    J Immunol. 2022;208:1857-1872.
    >> Share

  15. YANG X, Rutkovsky AC, Zhou J, Zhong Y, et al
    Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients.
    J Immunol. 2022;208:1968-1977.
    >> Share

  16. ZHAI B, Clarke K, Bauer DL, Moehling Geffel KK, et al
    SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients.
    J Immunol. 2022;208:1711-1718.
    >> Share

    March 2022
  17. JEONG S, Jeon M, Lee H, Kim SY, et al
    IFITM3 Is Upregulated Characteristically in IL-15-Mediated Bystander-Activated CD8(+) T Cells during Influenza Infection.
    J Immunol. 2022 Mar 28. pii: jimmunol.2100629. doi: 10.4049/jimmunol.2100629.
    >> Share

  18. DHUME K, Finn CM, Devarajan P, Singh A, et al
    Bona Fide Th17 Cells without Th1 Functional Plasticity Protect against Influenza.
    J Immunol. 2022 Mar 25. pii: jimmunol.2100801. doi: 10.4049/jimmunol.2100801.
    >> Share

  19. COSTANTINI VP, Nguyen K, Lyski Z, Novosad S, et al
    Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG.
    J Immunol. 2022;208:1500-1508.
    >> Share

  20. HAZAN G, Eubanks A, Gierasch C, Atkinson J, et al
    Age-Dependent Reduction in Asthmatic Pathology through Reprogramming of Postviral Inflammatory Responses.
    J Immunol. 2022;208:1467-1482.
    >> Share

  21. GAO X, Zhu B, Wu Y, Li C, et al
    TFAM-Dependent Mitochondrial Metabolism Is Required for Alveolar Macrophage Maintenance and Homeostasis.
    J Immunol. 2022;208:1456-1466.
    >> Share

  22. YUZEFPOLSKIY Y, Morawski P, Fahning M, Speake C, et al
    Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.
    J Immunol. 2022 Mar 14. pii: jimmunol.2101142. doi: 10.4049/jimmunol.2101142.
    >> Share

    February 2022
  23. MEYER-ARNDT L, Schwarz T, Loyal L, Henze L, et al
    Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4(+) T Cells following BNT162b2 Vaccination in the Elderly.
    J Immunol. 2022 Feb 4. pii: jimmunol.2100990. doi: 10.4049/jimmunol.2100990.
    >> Share

  24. NICOLI F, Cabral-Piccin MP, Papagno L, Gallerani E, et al
    Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8(+) T Cells in Elderly Humans.
    J Immunol. 2022;208:562-570.
    >> Share

  25. SUI C, Xiao T, Zhang S, Zeng H, et al
    SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy.
    J Immunol. 2022;208:753-761.
    >> Share

  26. DUTT TS, LaVergne SM, Webb TL, Baxter BA, et al
    Comprehensive Immune Profiling Reveals CD56(+) Monocytes and CD31(+) Endothelial Cells Are Increased in Severe COVID-19 Disease.
    J Immunol. 2022;208:685-696.
    >> Share

    January 2022
  27. KOMISSAROV AA, Dolzhikova IV, Efimov GA, Logunov DY, et al
    Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine.
    J Immunol. 2022 Jan 31. pii: jimmunol.2101052. doi: 10.4049/jimmunol.2101052.
    >> Share

  28. TU MK, Chiang SH, Bender RA, Wong DTW, et al
    The Kinetics of COVID-19 Vaccine Response in a Community-Vaccinated Population.
    J Immunol. 2022 Jan 17. pii: jimmunol.2100919. doi: 10.4049/jimmunol.2100919.
    >> Share

  29. LAW JC, Girard M, Chao GYC, Ward LA, et al
    Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset.
    J Immunol. 2022;208:429-443.
    >> Share

  30. HOPE JL, Zhao M, Stairiker CJ, Kiernan CH, et al
    MicroRNA-139 Expression Is Dispensable for the Generation of Influenza-Specific CD8(+) T Cell Responses.
    J Immunol. 2022 Jan 12. pii: jimmunol.2000621. doi: 10.4049/jimmunol.2000621.
    >> Share

  31. HARTWIG SM, Miller AM, Varga SM
    Respiratory Syncytial Virus Provides Protection against a Subsequent Influenza A Virus Infection.
    J Immunol. 2022 Jan 12. pii: jimmunol.2000751. doi: 10.4049/jimmunol.2000751.
    >> Share

  32. WU B, Ramaiah A, Garcia G Jr, Hasiakos S, et al
    ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling.
    J Immunol. 2022;208:74-84.
    >> Share

    November 2021
  33. LIU Y, Budylowski P, Dong S, Li Z, et al
    SARS-CoV-2-Reactive Mucosal B Cells in the Upper Respiratory Tract of Uninfected Individuals.
    J Immunol. 2021;207:2581-2588.
    >> Share

  34. HUSSAIN SA, Rohlfing M, Resiliac J, Santoro J, et al
    Atopic Neutrophils Prevent Postviral Airway Disease.
    J Immunol. 2021;207:2589-2597.
    >> Share

  35. JEEWANDARA C, Guruge D, Pushpakumara PD, Kamaladasa A, et al
    Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka.
    J Immunol. 2021 Nov 8. pii: jimmunol.2100762. doi: 10.4049/jimmunol.2100762.
    >> Share

  36. GAJANAYAKA N, Dong SXM, Ali H, Iqbal S, et al
    TLR-4 Agonist Induces IFN-gamma Production Selectively in Proinflammatory Human M1 Macrophages through the PI3K-mTOR- and JNK-MAPK-Activated p70S6K Pathway.
    J Immunol. 2021;207:2310-2324.
    >> Share

    October 2021
  37. WANG Y, Karki R, Zheng M, Kancharana B, et al
    Cutting Edge: Caspase-8 Is a Linchpin in Caspase-3 and Gasdermin D Activation to Control Cell Death, Cytokine Release, and Host Defense during Influenza A Virus Infection.
    J Immunol. 2021 Oct 18. pii: jimmunol.2100757. doi: 10.4049/jimmunol.2100757.
    >> Share

  38. BANSAL S, Perincheri S, Fleming T, Poulson C, et al
    Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines.
    J Immunol. 2021 Oct 15. pii: jimmunol.2100637. doi: 10.4049/jimmunol.2100637.
    >> Share

  39. PAIDI RK, Jana M, Mishra RK, Dutta D, et al
    Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    J Immunol. 2021 Oct 13. pii: jimmunol.2100144. doi: 10.4049/jimmunol.2100144.
    >> Share

  40. YANG Q, Wen Y, Qi F, Gao X, et al
    Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.
    J Immunol. 2021;207:1848-1856.
    >> Share

  41. SCOTT J, Ruchaud-Sparagano MH, Musgrave K, Roy AI, et al
    Phosphoinositide 3-Kinase delta Inhibition Improves Neutrophil Bacterial Killing in Critically Ill Patients at High Risk of Infection.
    J Immunol. 2021;207:1776-1784.
    >> Share

    September 2021
  42. ALVES I, Vicente MM, Gaifem J, Fernandes A, et al
    SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis.
    J Immunol. 2021;207:1591-1598.
    >> Share


  43. Top Reads.
    J Immunol. 2021;207:1495.
    >> Share

  44. MA T, Ryu H, McGregor M, Babcock B, et al
    Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8(+) T Cells during Convalescence.
    J Immunol. 2021;207:1344-1356.
    >> Share

    August 2021
  45. SHAHBAZ S, Xu L, Sligl W, Osman M, et al
    The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated.
    J Immunol. 2021;207:1099-1111.
    >> Share

  46. OCHSNER SP, Li W, Rajendrakumar AM, Palaniyandi S, et al
    FcRn-Targeted Mucosal Vaccination against Influenza Virus Infection.
    J Immunol. 2021 Aug 11. pii: jimmunol.2100297. doi: 10.4049/jimmunol.2100297.
    >> Share

  47. VERMA AK, Bauer C, Palani S, Metzger DW, et al
    IFN-gamma Drives TNF-alpha Hyperproduction and Lethal Lung Inflammation during Antibiotic Treatment of Postinfluenza Staphylococcus aureus Pneumonia.
    J Immunol. 2021 Aug 11. pii: jimmunol.2100328. doi: 10.4049/jimmunol.2100328.
    >> Share

  48. REYNOLDS D, Vazquez Guillamet C, Day A, Borcherding N, et al
    Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.
    J Immunol. 2021 Aug 4. pii: jimmunol.2100294. doi: 10.4049/jimmunol.2100294.
    >> Share

  49. BAYARRI-OLMOS R, Idorn M, Rosbjerg A, Perez-Alos L, et al
    SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
    J Immunol. 2021;207:878-887.
    >> Share

    July 2021
  50. AVENDANO-ORTIZ J, Lozano-Rodriguez R, Martin-Quiros A, Maroun-Eid C, et al
    SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.
    J Immunol. 2021;207:162-174.
    >> Share


  51. Top Reads.
    J Immunol. 2021;207:1-2.
    >> Share

    June 2021
  52. MATCHETT WE, Joag V, Stolley JM, Shepherd FK, et al
    Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.
    J Immunol. 2021 Jun 30. pii: jimmunol.2100421. doi: 10.4049/jimmunol.2100421.
    >> Share

  53. MARTINI V, Paudyal B, Chrun T, McNee A, et al
    Correction: Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.
    J Immunol. 2021 Jun 18. pii: jimmunol.2100261. doi: 10.4049/jimmunol.2100261.
    >> Share

  54. LIU X, Zhao J, Wang H, Wang W, et al
    Metabolic Defects of Peripheral T Cells in COVID-19 Patients.
    J Immunol. 2021;206:2900-2908.
    >> Share


  55. Top Reads.
    J Immunol. 2021;206:2773-2774.
    >> Share

  56. HOEHN KB, Ramanathan P, Unterman A, Sumida TS, et al
    Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19.
    J Immunol. 2021;206:2785-2790.
    >> Share

  57. SANDOR AM, Sturdivant MS, Ting JPY
    Influenza Virus and SARS-CoV-2 Vaccines.
    J Immunol. 2021;206:2509-2520.
    >> Share

  58. JAHRSDORFER B, Gross R, Seidel A, Wettstein L, et al
    Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors.
    J Immunol. 2021;206:2614-2622.
    >> Share

  59. MANTUS G, Nyhoff LE, Kauffman RC, Edara VV, et al
    Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain.
    J Immunol. 2021;206:2605-2613.
    >> Share

    May 2021
  60. OCCHIGROSSI L, Rossin F, D'Eletto M, Farrace MG, et al
    Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis.
    J Immunol. 2021;206:2420-2429.
    >> Share

  61. FUJIGAKI H, Inaba M, Osawa M, Moriyama S, et al
    Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients.
    J Immunol. 2021;206:2393-2401.
    >> Share

  62. YAN Q, Li P, Ye X, Huang X, et al
    Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
    J Immunol. 2021;206:2146-2159.
    >> Share

    April 2021
  63. CROOKE PS 3RD, Tossberg JT, Porter KP, Aune TM, et al
    Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.
    J Immunol. 2021;206:1691-1696.
    >> Share

  64. HUANG W, Li M, Luo G, Wu X, et al
    The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression.
    J Immunol. 2021;206:1597-1608.
    >> Share

  65. RUPP J, Dreo B, Gutl K, Fessler J, et al
    T Cell Phenotyping in Individuals Hospitalized with COVID-19.
    J Immunol. 2021;206:1478-1482.
    >> Share

  66. FRANZETTI M, Forastieri A, Borsa N, Pandolfo A, et al
    IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study.
    J Immunol. 2021;206:1569-1575.
    >> Share

  67. PRICE MJ, Scharer CD, Kania AK, Randall TD, et al
    Conserved Epigenetic Programming and Enhanced Heme Metabolism Drive Memory B Cell Reactivation.
    J Immunol. 2021;206:1493-1504.
    >> Share

    March 2021
  68. MALINCZAK CA, Parolia A, Fonseca W, Morris S, et al
    TSLP-Driven Chromatin Remodeling and Trained Systemic Immunity after Neonatal Respiratory Viral Infection.
    J Immunol. 2021;206:1315-1328.
    >> Share

    February 2021
  69. TIAN J, Zhang M, Jin M, Zhang F, et al
    Repurposed Tocilizumab in Patients with Severe COVID-19.
    J Immunol. 2021;206:599-606.
    >> Share

  70. ZELBA H, Worbs D, Harter J, Pieper N, et al
    A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4(+) and CD8(+) T Cells in COVID-19 Patients.
    J Immunol. 2021;206:580-587.
    >> Share

    January 2021
  71. SCHWARZ B, Sharma L, Roberts L, Peng X, et al
    Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators.
    J Immunol. 2021;206:329-334.
    >> Share

  72. JOAG V, Wijeyesinghe S, Stolley JM, Quarnstrom CF, et al
    Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.
    J Immunol. 2021 Jan 13. pii: jimmunol.2001400. doi: 10.4049/jimmunol.2001400.
    >> Share

  73. HANSEN CB, Jarlhelt I, Perez-Alos L, Hummelshoj Landsy L, et al
    SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.
    J Immunol. 2021;206:109-117.
    >> Share

    December 2020
  74. MARTINI V, Paudyal B, Chrun T, McNee A, et al
    Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.
    J Immunol. 2020 Dec 16. pii: jimmunol.2001086. doi: 10.4049/jimmunol.2001086.
    >> Share

  75. VOGELZANG EH, Loeff FC, Derksen NIL, Kruithof S, et al
    Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19.
    J Immunol. 2020;205:3491-3499.
    >> Share

  76. MARTINEZ-FLETA P, Alfranca A, Gonzalez-Alvaro I, Casasnovas JM, et al
    SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.
    J Immunol. 2020;205:3130-3140.
    >> Share

  77. KELLAR GG, Reeves SR, Barrow KA, Debley JS, et al
    Juvenile, but Not Adult, Mice Display Increased Myeloid Recruitment and Extracellular Matrix Remodeling during Respiratory Syncytial Virus Infection.
    J Immunol. 2020;205:3050-3057.
    >> Share

    November 2020
  78. LAW JC, Koh WH, Budylowski P, Lin J, et al
    Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.
    J Immunol. 2020 Nov 18. pii: jimmunol.2001067. doi: 10.4049/jimmunol.2001067.
    >> Share

  79. KALKAN YAZICI M, Koc MM, Cetin NS, Karaaslan E, et al
    Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.
    J Immunol. 2020;205:2719-2725.
    >> Share

  80. NOWILL AE, de Campos-Lima PO
    Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
    J Immunol. 2020;205:2566-2575.
    >> Share

  81. BAUMGARTH N, Nikolich-Zugich J, Lee FE, Bhattacharya D, et al
    Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.
    J Immunol. 2020;205:2342-2350.
    >> Share

  82. VARNAITE R, Garcia M, Glans H, Maleki KT, et al
    Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    J Immunol. 2020;205:2437-2446.
    >> Share

    October 2020
  83. ELAHI S
    Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy.
    J Immunol. 2020;205:1990-1997.
    >> Share

    September 2020
  84. SOKULSKY LA, Garcia-Netto K, Nguyen TH, Girkin JLN, et al
    A Critical Role for the CXCL3/CXCL5/CXCR2 Neutrophilic Chemotactic Axis in the Regulation of Type 2 Responses in a Model of Rhinoviral-Induced Asthma Exacerbation.
    J Immunol. 2020 Sep 18. pii: jimmunol.1901350. doi: 10.4049/jimmunol.1901350.
    >> Share

  85. WONG LR, Ye ZW, Lui PY, Zheng X, et al
    Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKepsilon.
    J Immunol. 2020;205:1564-1579.
    >> Share

  86. LO MW, Kemper C, Woodruff TM
    COVID-19: Complement, Coagulation, and Collateral Damage.
    J Immunol. 2020;205:1488-1495.
    >> Share

  87. XIA J, Kuang Y, Liang J, Jones M, et al
    Influenza Vaccine-Induced CD4 Effectors Require Antigen Recognition at an Effector Checkpoint to Generate CD4 Lung Memory and Antibody Production.
    J Immunol. 2020 Sep 14. pii: jimmunol.2000597. doi: 10.4049/jimmunol.2000597.
    >> Share

  88. FRANCO R, Rivas-Santisteban R, Serrano-Marin J, Rodriguez-Perez AI, et al
    SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.
    J Immunol. 2020;205:1198-1206.
    >> Share

    August 2020
  89. ASSMUS LM, Guan J, Wu T, Farenc C, et al
    Overlapping Peptides Elicit Distinct CD8(+) T Cell Responses following Influenza A Virus Infection.
    J Immunol. 2020 Aug 31. pii: jimmunol.2000689. doi: 10.4049/jimmunol.2000689.
    >> Share

  90. ORLOV M, Wander PL, Morrell ED, Mikacenic C, et al
    A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections.
    J Immunol. 2020;205:892-898.
    >> Share

  91. ALSOUSSI WB, Turner JS, Case JB, Zhao H, et al
    A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.
    J Immunol. 2020;205:915-922.
    >> Share

  92. VERMA AK, Bansal S, Bauer C, Muralidharan A, et al
    Influenza Infection Induces Alveolar Macrophage Dysfunction and Thereby Enables Noninvasive Streptococcus pneumoniae to Cause Deadly Pneumonia.
    J Immunol. 2020 Aug 12. pii: jimmunol.2000094. doi: 10.4049/jimmunol.2000094.
    >> Share

  93. ST JOHN AL, Rathore APS
    Early Insights into Immune Responses during COVID-19.
    J Immunol. 2020;205:555-564.
    >> Share

    July 2020
  94. YAP JKY, Moriyama M, Iwasaki A
    Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.
    J Immunol. 2020;205:307-312.
    >> Share

  95. CHEN J, Kelley WJ, Goldstein DR
    Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.
    J Immunol. 2020;205:313-320.
    >> Share

  96. MANJILI RH, Zarei M, Habibi M, Manjili MH, et al
    COVID-19 as an Acute Inflammatory Disease.
    J Immunol. 2020;205:12-19.
    >> Share

    June 2020
  97. MCNEE A, Smith TRF, Holzer B, Clark B, et al
    Establishment of a Pig Influenza Challenge Model for Evaluation of Monoclonal Antibody Delivery Platforms.
    J Immunol. 2020 Jun 26. pii: jimmunol.2000429. doi: 10.4049/jimmunol.2000429.
    >> Share

  98. CASALINO-MATSUDA SM, Chen F, Gonzalez-Gonzalez FJ, Nair A, et al
    Hypercapnia Suppresses Macrophage Antiviral Activity and Increases Mortality of Influenza A Infection via Akt1.
    J Immunol. 2020 Jun 15. pii: jimmunol.2000085. doi: 10.4049/jimmunol.2000085.
    >> Share

  99. TOBIN JM, Nickolich KL, Ramanan K, Pilewski MJ, et al
    Influenza Suppresses Neutrophil Recruitment to the Lung and Exacerbates Secondary Invasive Pulmonary Aspergillosis.
    J Immunol. 2020 Jun 10. pii: jimmunol.2000067. doi: 10.4049/jimmunol.2000067.
    >> Share

    May 2020
  100. ALAM F, Singh A, Flores-Malavet V, Sell S, et al
    CD25-Targeted IL-2 Signals Promote Improved Outcomes of Influenza Infection and Boost Memory CD4 T Cell Formation.
    J Immunol. 2020 May 6. pii: jimmunol.2000205. doi: 10.4049/jimmunol.2000205.
    >> Share

    February 2020
  101. AVEY S, Mohanty S, Chawla DG, Meng H, et al
    Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults.
    J Immunol. 2020 Feb 14. pii: jimmunol.1900922. doi: 10.4049/jimmunol.1900922.
    >> Share

    January 2020
  102. BLUNDELL PA, Lu D, Dell A, Haslam S, et al
    Choice of Host Cell Line Is Essential for the Functional Glycosylation of the Fc Region of Human IgG1 Inhibitors of Influenza B Viruses.
    J Immunol. 2020 Jan 6. pii: jimmunol.1901145. doi: 10.4049/jimmunol.1901145.
    >> Share

  103. MALINCZAK CA, Rasky AJ, Fonseca W, Schaller MA, et al
    Upregulation of H3K27 Demethylase KDM6 During Respiratory Syncytial Virus Infection Enhances Proinflammatory Responses and Immunopathology.
    J Immunol. 2020;204:159-168.
    >> Share

    December 2019
  104. SAUTTO GA, Kirchenbaum GA, Abreu RB, Ecker JW, et al
    A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin.
    J Immunol. 2019 Dec 6. pii: jimmunol.1900379. doi: 10.4049/jimmunol.1900379.
    >> Share

    November 2019
  105. ZACHARIAS ZR, Legge KL
    Chronic Ethanol Consumption Reduces Existing CD8 T Cell Memory and Is Associated with Lesions in Protection against Secondary Influenza A Virus Infections.
    J Immunol. 2019 Nov 11. pii: jimmunol.1900770. doi: 10.4049/jimmunol.1900770.
    >> Share

    April 2019
  106. SCHMIDT ME, Oomens AGP, Varga SM
    Vaccination with a Single-Cycle Respiratory Syncytial Virus Is Immunogenic and Protective in Mice.
    J Immunol. 2019 Apr 19. pii: jimmunol.1900050. doi: 10.4049/jimmunol.1900050.
    >> Share

    February 2019
  107. PERCOPO CM, Ma M, Brenner TA, Krumholz JO, et al
    Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection.
    J Immunol. 2019;202:871-882.
    >> Share

    January 2019
  108. JAMIESON KC, Traves SL, Kooi C, Wiehler S, et al
    Rhinovirus and Bacteria Synergistically Induce IL-17C Release from Human Airway Epithelial Cells To Promote Neutrophil Recruitment.
    J Immunol. 2019;202:160-170.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016